Boston Scientific Corporation (BSX) vs Humana Inc. (HUM)
BSX leads on 13 of 15 compared metrics.
A side-by-side comparison of Boston Scientific Corporation and Humana Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 17, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
Total return — BSX vs HUM
growth of $100 · last 30yBSX +372.2%HUM +1913.4%HUM compounded faster
BSX HUM
BSX vs HUM: by the numbers
- •BSX is the larger company ($69.74B vs $45.03B market cap).
- •BSX trades at the lower earnings multiple (19.71 vs 40.67 P/E).
- •BSX converts more revenue to profit (17.24% vs 0.82% net margin).
- •BSX grew revenue faster over the past five years (15.29% vs 11.71% CAGR).
- •HUM pays a dividend (0.93% yield) while BSX does not currently pay one.
Which is better, BSX or HUM?
Metric tally: BSX 13 · HUM 2It depends on what you're optimizing for:
ValueBSX(lower P/E)
GrowthBSX(faster 5Y revenue CAGR)
QualityBSX(higher ROIC)
Metrics side by side
Valuation
| Metric | BSX | HUM |
|---|---|---|
| P/E ratio | 19.71● | 40.67 |
| Forward P/E | 12.60● | 24.00 |
| P/S ratio | 3.40 | 0.33● |
| P/B ratio | 2.71 | 2.47● |
| PEG ratio | 0.88 | — |
| EV / EBITDA | 14.07● | 19.26 |
| FCF yield | 4.91%● | 2.77% |
Profitability
| Metric | BSX | HUM |
|---|---|---|
| Gross margin | 70.41%● | 14.01% |
| Operating margin | 20.12%● | 1.01% |
| Net margin | 17.24%● | 0.82% |
| ROE | 13.74%● | 6.08% |
| ROIC | 8.78%● | 3.12% |
Dividends
| Metric | BSX | HUM |
|---|---|---|
| Dividend yield | — | 0.93% |
| Payout ratio | — | 35.87% |
Growth (annualized)
| Metric | BSX | HUM |
|---|---|---|
| Revenue CAGR (5Y) | 15.29%● | 11.71% |
| EPS CAGR (5Y) | -8.67%● | -17.27% |
| FCF CAGR (5Y) | 19.89%● | -17.19% |
| Total return CAGR (5Y) | 1.86%● | -1.65% |
Frequently asked
- Which is better, BSX or HUM?
- It depends on your goal. value: BSX (lower P/E); growth: BSX (faster 5Y revenue CAGR); quality: BSX (higher ROIC). Across all compared metrics, BSX leads 13 to 2.
- Is BSX or HUM cheaper?
- On trailing earnings, BSX is cheaper: BSX trades at a 19.71 P/E and HUM at 40.67.
- Which has grown faster, BSX or HUM?
- Over the past five years, BSX grew revenue faster — BSX at a 15.29% CAGR versus HUM at 11.71%.
- Does BSX or HUM pay a bigger dividend?
- HUM pays a dividend (0.93% yield) while BSX does not currently pay one.
- Is BSX or HUM more profitable?
- BSX runs the higher net margin — BSX at 17.24% versus HUM at 0.82%.
- Which has been the better investment, BSX or HUM?
- Over the past 10-year, HUM delivered the higher annualized total return — BSX at 7.47% versus HUM at 8.11%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Boston Scientific P/E ratioHumana P/E ratioBoston Scientific dividend yieldHumana dividend yieldBoston Scientific ROEHumana ROEBoston Scientific operating marginHumana operating marginBoston Scientific revenue growthHumana revenue growthBoston Scientific free cash flowHumana free cash flow
Boston Scientific & Humana appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 17, 2026.